BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8838078)

  • 1. [Recent advances in molecular biology with respect to pulmonary surfactant apoproteins].
    Kuroki Y; Ogasawara Y
    Nihon Rinsho; 1996 Feb; 54(2):334-40. PubMed ID: 8838078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biochemical and clinical aspects of pulmonary surfactant proteins].
    Akino T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():5-14. PubMed ID: 1306239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-lipid interactions and surface activity in the pulmonary surfactant system.
    Serrano AG; Pérez-Gil J
    Chem Phys Lipids; 2006 Jun; 141(1-2):105-18. PubMed ID: 16600200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and function of pulmonary surfactant protein B.
    Pryhuber GS
    Mol Genet Metab; 1998 Aug; 64(4):217-28. PubMed ID: 9758711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent advances in pulmonary surfactant research with special reference to surfactant apoproteins].
    Akino T; Kuroki Y
    Kokyu To Junkan; 1990 Aug; 38(8):722-35. PubMed ID: 2218080
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of synthetic peptides in the formation of biophysically and biologically active pulmonary surfactants.
    Revak SD; Merritt TA; Hallman M; Heldt G; La Polla RJ; Hoey K; Houghten RA; Cochrane CG
    Pediatr Res; 1991 May; 29(5):460-5. PubMed ID: 1896249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host defense functions of pulmonary surfactant.
    Wright JR
    Biol Neonate; 2004; 85(4):326-32. PubMed ID: 15211087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of surfactant lipid turnover in silicosis: evidence of a role for surfactant-associated protein A (SP-A).
    Lesur O; Bouhadiba T; Melloni B; Cantin A; Whitsett JA; Bégin R
    Int J Exp Pathol; 1995 Aug; 76(4):287-98. PubMed ID: 7547443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant protein B: structure and function.
    Hawgood S
    Biol Neonate; 2004; 85(4):285-9. PubMed ID: 15218284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A.
    Venkitaraman AR; Hall SB; Whitsett JA; Notter RH
    Chem Phys Lipids; 1990 Dec; 56(2-3):185-94. PubMed ID: 2095991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.
    Palmblad M; Johansson J; Robertson B; Curstedt T
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):381-6. PubMed ID: 10191270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Function of lung surfactant and its deterioration].
    Osanai K
    Rinsho Byori; 2002 Apr; 50(4):365-9. PubMed ID: 12014015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the low-molecular weight (less than or equal to 15,000 daltons) apoproteins of pulmonary surfactant.
    Suzuki Y; Curstedt T; Grossmann G; Kobayashi T; Nilsson R; Nohara K; Robertson B
    Eur J Respir Dis; 1986 Nov; 69(5):336-45. PubMed ID: 3792469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical, biological and genetic heterogeneity of the inborn errors of pulmonary surfactant metabolism: SP-B deficiency and alveolar proteinosis].
    Tredano M; Blic JD; Griese M; Fournet JC; Elion J; Bahuau M
    Ann Biol Clin (Paris); 2001; 59(2):131-48. PubMed ID: 11282516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The ocular surfactant system and its relevance in the dry eye].
    Schicht M; Posa A; Paulsen F; Bräuer L
    Klin Monbl Augenheilkd; 2010 Nov; 227(11):864-70. PubMed ID: 21077020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant-associated proteins (SP-A, SP-B) are increased proportionally to alveolar phospholipids in sheep silicosis.
    Lesur O; Veldhuizen RA; Whitsett JA; Hull WM; Possmayer F; Cantin A; Bégin R
    Lung; 1993; 171(2):63-74. PubMed ID: 8426464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.
    Revak SD; Merritt TA; Degryse E; Stefani L; Courtney M; Hallman M; Cochrane CG
    J Clin Invest; 1988 Mar; 81(3):826-33. PubMed ID: 3343343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrophobic surfactant proteins and their analogues.
    Walther FJ; Waring AJ; Sherman MA; Zasadzinski JA; Gordon LM
    Neonatology; 2007; 91(4):303-10. PubMed ID: 17575474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant protein B and C analogues.
    Walther FJ; Gordon LM; Zasadzinski JA; Sherman MA; Waring AJ
    Mol Genet Metab; 2000; 71(1-2):342-51. PubMed ID: 11001826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical inhibition of synthetic phospholipid-lung surfactant apoprotein admixtures by plasma proteins.
    Venkitaraman AR; Baatz JE; Whitsett JA; Hall SB; Notter RH
    Chem Phys Lipids; 1991; 57(1):49-57. PubMed ID: 2060063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.